Midatech receives Orphan Drug Designation for MTD119 from the European Medicines Agency Pharmaceutical Investing
BeiGene Announces Approval of REVLIMID® for Newly Diagnosed Multiple Myeloma in China Pharmaceutical Investing
Mesoblast Operational Highlights and Financial Results for the Half-Year Ended December 31, 2017 Genetics Investing
Cidara Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results Biotech Investing
Supernus Announces Record Full Year 2017 Financial Results, Exceeding Operating Earnings Guidance Pharmaceutical Investing
Capital Senior Living Corporation Reports Fourth Quarter and Full Year 2017 Results Longevity Investing
GBT Reports Recent Business Progress and Fourth Quarter and Year-End 2017 Financial Results Biotech Investing
Wright Medical Group N.V. Reports 2017 Fourth Quarter and Full-Year Financial Results and Provides 2018 Annual Guidance Medical Device Investing
InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial
InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline
